Skip to content
ppharmaranks
Menu

Best treatments for pulmonary emphysema

5 products may treat pulmonary emphysema, spanning FDA drug classes such as anticholinergic, beta2-adrenergic agonist. The current highest-rated option is atrovent hfa. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 5 drugs we list for pulmonary emphysema, 3 are available as lower-cost generics, spanning classes such as anticholinergic, beta2-adrenergic agonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for pulmonary emphysema — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Top-rated picks for pulmonary emphysema: 1. Atrovent Hfa · 2. Spiriva Respimat · 3. Striverdi Respimat

Top-rated treatments for pulmonary emphysema, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100$1View →
272/100$354View →
372/100View →
470/100$354View →
5Not yet ratedView →

Narrow by drug class

Explore the class hubs: anticholinergic

Full ranking · 5 treatments

Frequently asked

What treats pulmonary emphysema?
Our catalog lists 5 products that may treat pulmonary emphysema, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is atrovent hfa.
What is the best-rated treatment for pulmonary emphysema?
By our independent recall-safety rating — not an efficacy measure — atrovent hfa ranks highest among the products we list for pulmonary emphysema. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat pulmonary emphysema?
Treatments for pulmonary emphysema span FDA drug classes including anticholinergic, beta2-adrenergic agonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.